Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nasdaq

One is subject to market forces, while the other is subject to financial engineering.

Better Buy: CME Group vs. Nasdaq

Moody's

Activision Blizzard

Dollar General

Microsoft

Peter Simmie's Bristol Gate Capital Partners is a Toronto, Canada-based hedge fund that invests primarily in dividend stocks. Bristol Gate uses both machine learning and fundamental analysis tools to uncover stocks with strong dividend growth prospects. The firm, which was founded in 2006 by Mr. Simmie, who currently serves as its Chief Investment Officer, believes that by focusing on a concentrated portfolio of stocks with strong dividend growth potential over the coming 12 months, it can build a portfolio that will beat the market over the long-term while limiting downside risk.

5 Stocks That Could Massively Grow Their Dividends in 2021 and Beyond

The Fed's actions are a problem for the stock.

CME Group Earnings Suffer Due to Dull Bond Market

CHICAGO, Nov. 3, 2020 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today reported October 2020 market statistics, including average daily volume (ADV) of 15.4 million contracts during the month. Market statistics are available in greater detail...

CME Group Reports October 2020 Monthly Market Statistics

Advanced Micro Devices

NVIDIA

PayPal

Block

Interest in cryptocurrency is surging once again with Bitcoin prices up by almost 30% over the last month, driven by growing institutional interest and Paypal's recent move to allow its customers to buy and sell certain cryptocurrencies. Our indicative theme on Cryptocurrency Stocks.

Cryptocurrency Stocks To Watch As Bitcoin Prices Surge

CME Group Inc. (CME) CEO Terrence Duffy on Q3 2020 Results - Earnings Call Transcript

The stock missed estimates on lower average daily volume on its exchanges.

CME Group Stock Trading Lower on Q3 Earnings Drop

CME Group (CME) Q3 results reflect lower clearing and transaction fees and decrease in average daily volume in three out of the six products lines.

CME Group (CME) Q3 Earnings and Revenues Miss Estimates

CME (CME) delivered earnings and revenue surprises of -2.13% and -1.04%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

CME Group (CME) Q3 Earnings and Revenues Lag Estimates

Intercontinental Exchange

Volatility and volume combine for another strong quarter.

A Volatile Stock Market Is Still Great for Nasdaq

CME Group's (CME) third-quarter performance is likely to have benefited from clearing and transaction fees, market data and information services revenues and derivative product lines.

CME Group (CME) to Report Q3 Earnings: What's in the Cards?

CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: CME Group (CME) Q3 Earnings Expected to Decline

CME Group hasn’t had a stellar year – in fact, they’ve underperformed the S&P 500 since the start. Though the market can’t seem to make up its mind on CME, the company appears to be in overall good shape.

CME Group Receives Attractive Rating For October

CME Group's (CME) average daily volume for September and third-quarter 2020 decreases primarily due to lower volumes across most of its product lines.

CME Group (CME) September ADV Decreases Y/Y, Q3 Volumes Soft

In partnership with Nasdaq Inc (NASDAQ: NDAQ), CME Group Inc (NASDAQ: CME), the world’s largest derivatives marketplace, formally announced it plans to launch a futures contract this year based on the Nasdaq Veles California Water Index (NQH20). As part of the development, Benzinga chatted with Tim McCourt, global head of equity index and alternative investment products, to discuss CME Group’s impact on innovation- and sustainability-driven financial markets.

CME Group Tackles Water Scarcity With New Futures Contract

CHICAGO, Oct. 2, 2020 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today reported its September and third-quarter 2020 market statistics, showing it reached average daily volume (ADV) of 15.6 million contracts during the quarter and 16.9 million...

CME Group Reports September and Third-Quarter 2020 Market Statistics

CME Group (CME) will launch Pork Cutout futures and options to enable risk management and improve market visibility.

CME Group Set to Introduce Pork Cutout Futures and Options

CME Group (CME) is poised to grow, given its top-line strength, highly diverse product set and prudent capital deployment, offset by higher expenses.

Here's Why You Should Retain CME Group (CME) in Your Portfolio

CHICAGO, Sept. 25, 2020 /PRNewswire/ -- CME Group Inc. will announce earnings for the third quarter of 2020 before the markets open on Wednesday, October 28, 2020. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it...

CME Group Inc. Announces Third-Quarter 2020 Earnings Release, Conference Call

CME Group (CME) boosts its portfolio of energy futures and options with the first trade of European renewable fuel contract.

CME Group Declares Trading of UCO & UCOME Futures Contracts

The exchange operator's new contracts will be based on a California water index managed by Nasdaq.

CME Group Launching "First-of-its-Kind" Water Futures Product

Cboe Global Markets

Why You Shouldn't Trade In-The-Money Options

CHICAGO, Sept. 15, 2020 /PRNewswire/ -- CME Group announced today that Sean Tully, Global Head of Financial and OTC Products, and John Peschier, Managing Director of Investor Relations, will present at the Raymond James 16th Annual North American Equities Conference on Thursday, September.

CME Group Global Head of Financial and OTC Products and Managing Director of Investor Relations to Present at Raymond James North American Equities Conference

CHICAGO, Sept. 15, 2020 /PRNewswire/ -- CME Group announced today that John Pietrowicz, Chief Financial Officer, Sean Tully, Global Head of Financial and OTC Products, and Derek Sammann, Global Head of Commodities and Options Products, will present at the Barclays Global Financial.

CME Group Chief Financial Officer, Global Head of Financial and OTC Products and Global Head of Commodities and Options Products to Present at Barclays Global Financial Services Conference

CME Group (CME) brings first-ever FX Options Vol Converter tool to enhance transparency and improve decision making.

News for CME Group Stock (CME)